Find, compare & contact
Managlinat dialanetil
API Manufacturers & Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Managlinat dialanetil API 280782-97-0?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Managlinat dialanetil. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Managlinat dialanetil
- Synonyms:
- Managlinat dialanétil , Managlinat dialanetilo , Managlinatum dialanetilum
- Cas Number:
- 280782-97-0
- DrugBank number:
- DB05518
- Unique Ingredient Identifier:
- 3W93F83K7S
General Description:
Managlinat dialanetil, identified by CAS number 280782-97-0, is a notable compound with significant therapeutic applications. CS-917 is a novel inhibitor of fructose 1,6-bisphphosphatase (FBPase) which is one of the rate-limiting enzymes of gluconeogenesis.
Indications:
This drug is primarily indicated for: Investigated for use/treatment in diabetes mellitus type 2. Its use in specific medical scenarios underscores its importance in the therapeutic landscape.
Mechanism of Action:
Managlinat dialanetil functions by: In type 2 diabetes, the liver produces excessive amounts of glucose through the gluconeogenesis (GNG) pathway and consequently is partly responsible for the elevated glucose levels characteristic of the disease. CS-917 targets the AMP binding site of fructose 1,6-bisphosphatase (FBPase), inhibiting the GNC pathway. This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.
Categories:
Managlinat dialanetil is categorized under the following therapeutic classes: Amino Acids, Amino Acids, Peptides, and Proteins, Fructose-Bisphosphatase, antagonists & inhibitors, Organophosphorus Compounds. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Managlinat dialanetil is a type of Other substances
The pharmaceutical industry encompasses a diverse range of active pharmaceutical ingredients (APIs) that are used in the production of various medications. One category of APIs is known as other substances. This category includes substances that do not fall under the conventional classifications such as antibiotics, analgesics, or antihypertensives.
Other substances in pharmaceutical APIs consist of a broad array of chemical compounds with unique properties and applications. These substances play a crucial role in the formulation and development of specialized medications, catering to specific therapeutic needs. The category encompasses various substances like excipients, solvents, stabilizers, and pH adjusters.
Excipients are inert substances that aid in the manufacturing process and enhance the stability, bioavailability, and patient acceptability of pharmaceutical formulations. Solvents are used to dissolve other ingredients and facilitate their incorporation into the final product. Stabilizers ensure the integrity and shelf life of medications by preventing degradation or chemical changes. pH adjusters help maintain the desired pH level of a formulation, which can influence the drug's efficacy and stability.
Pharmaceutical manufacturers carefully select and incorporate specific other substances into their formulations, adhering to regulatory guidelines and quality standards. These substances undergo rigorous testing and evaluation to ensure their safety, efficacy, and compatibility with the desired pharmaceutical product. By employing other substances in API formulations, pharmaceutical companies can optimize drug delivery, improve patient compliance, and enhance therapeutic outcomes.
In summary, the other substances category of pharmaceutical APIs comprises a diverse range of chemicals, including excipients, solvents, stabilizers, and pH adjusters. These substances contribute to the formulation, stability, and performance of medications, enabling pharmaceutical manufacturers to develop specialized products that meet specific therapeutic requirements.
